3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration
Tissue and Cell · 2024-06 · 88 · 102418
DOI: 10.1016/j.tice.2024.102418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue and Cell, 2024-06. Verfasst von Wen Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Stomatological Hospital of Xuzhou Medical University, No.130 Huaihai West Road, Xuzhou, Jiangsu 221000, China. Hauptthemen laut MEDLINE: Bone Regeneration, Printing, Three-Dimensional, Hydrogels, Bioprinting. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Bioprinting technology promotes innovation of fabricating tissue engineered constructs. Dental pulp stem cells (DPSCs) have significant advantages over classical bone mesenchymal stem cells (BMSCs) and are a promising seed cell candidate for bone engineering bioprinting. However, current reports about bioprinted DPSCs for bone regeneration are incomprehensive. The objective of this study was to investigate the osteogenic potential of DPSCs in methacrylate gelatin (GelMA) hydrogels bioprinted scaffolds in vitro and in vivo. Firstly, we successfully bioprinted GelMA with different concentrations embedded with or without DPSCs. Printability, physical features and biological properties of the bioprinted constructs were evaluated. Then, osteogenic differentiation levels of DPSCs in bioprinted constructs with various concentrated GelMA were compared. Finally, effects of bioprinted constructs on cranial bone regeneration were evaluated in vivo. The results of our study demonstrated that 10% GelMA had higher compression modulus, smaller pores, lower swelling and degradation rate than 3% GelMA. Twenty-eight days after printing, DPSCs in three groups of bioprinted structures still maintained high cell activities (>90%). Moreover, DPSCs in 10% GelMA showed an upregulated expression of osteogenic markers and a highly activated ephrinB2/EphB4 signaling, a signaling involved in bone homeostasis. In vivo experiments showed that DPSCs survived at a higher rate in 10% GelMA, and more new bones were observed in DPSC-laden 10% GelMA group, compared with GelMA of other concentrations. In conclusion, bioprinted DPSC-laden 10% GelMA might be more appropriate for bone regeneration application, in contrast to GelMA with other concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Stomatological Hospital of Xuzhou Medical University, No.130 Huaihai West Road, Xuzhou, Jiangsu 221000, China.
- Quanzhou Women 's and Children's Hospital, NO.700 Fengze Street, Quanzhou, Fujian 362000, China.
- School of Stomatology, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou, Jiangsu 221004, China.
- Affiliated Stomatological Hospital of Xuzhou Medical University, No.130 Huaihai West Road, Xuzhou, Jiangsu 221000, China; School of Stomatology, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou, Jiangsu 221004,…
Zitieren
APA
Wang, W., Zhu, Y., Liu, Y., Chen, B., Li, M., Yuan, C., & Wang, P. (2024). 3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration. Tissue and Cell, 88, 102418. https://doi.org/10.1016/j.tice.2024.102418
Vancouver
Wang W, Zhu Y, Liu Y, Chen B, Li M, Yuan C, et al. 3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration. Tissue and Cell. 2024;88:102418. doi:10.1016/j.tice.2024.102418
BibTeX
@article{Wang2024,
author = {Wang, Wen and Zhu, Yaru and Liu, Ya and Chen, Banghui and Li, Mengying and Yuan, Changyong and Wang, Penglai},
title = {3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration},
journal = {Tissue and Cell},
year = {2024},
volume = {88},
pages = {102418},
doi = {10.1016/j.tice.2024.102418}
}
EUVIMED